Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry.
Renate B SchnabelPietro AmeriJolanta M Siller-MatulaIgor DiembergerMarianne GwechenbergerLadislav PecenMarius Constantin ManuJosé SouzaRaffaele De CaterinaPaulus F KirchhofPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
Anticoagulated patients with HF at baseline featured higher rates of major bleeding and all-cause death, requiring optimised management and novel preventive strategies. NOAC treatment was similarly effective in reducing risk of ischaemic events in patients with or without concomitant HF.